Updates in the Treatment of Mantle Cell Lymphoma

This article discusses the current treatment landscape and therapeutic strategies for mantle cell lymphoma, the role of Bruton tyrosine kinase inhibitor therapies in MCL, and insights on new regimens and ongoing clinical trials from leading experts in hematologic malignancies.

Related Videos
Jorge E. Cortes, MD
Bradley W. Christensen, MD
Expert on AML
Expert on AML
Akash Mukherjee, MD
Zachary Epstein-Peterson, MD
Andre H. Goy, MD
Craig Sauter, MD
Experts on AML
Expert on AML
Related Content